Entertainment Wire Massachusetts
SEE OTHER BRANDS

Your arts and entertainment news from Massachusetts

Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on May 27, 2025

Eröffnung der Cheongsam-Gala 2025 mit der Cheongsam-Show als Auftakt für die Cheongsam-Kultursaison in Shenyang

Eröffnung der Cheongsam-Gala 2025 mit der Cheongsam-Show als Auftakt für die Cheongsam-Kultursaison in Shenyang

SHENYANG, China, May 27, 2025 (GLOBE NEWSWIRE) -- Am 21. Mai hat im Skulpturenpark des Einkaufs- und Kunstzentrums K11 in Shenyang eine eindrucksvolle Modenschau unter dem Motto „Charm of Cheongsam in Shenyang, Encountering a Colorful New Life“ (Der Charme …

Parched Hospitality Group Puts the Guest Experience First with New Paytronix Rewards App

Parched Hospitality Group Puts the Guest Experience First with New Paytronix Rewards App

Loyalty with an Australian Vibe — Parched launches a tiered rewards program to engage and reward guests digitally, across its unique dining …

IBN Re-Engaged to Provide Real-Time Coverage of the 15th Annual London Conference

IBN Re-Engaged to Provide Real-Time Coverage of the 15th Annual London Conference

AUSTIN, Texas, May 27, 2025 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN ("InvestorBrandNetwork"), an innovative corporate communications firm and content distributor, is thrilled to announce its continued collaboration with ROTH Capital Partners, LLC (" …

Trump Media Announces Approximately $2.5 Billion Bitcoin Treasury Deal

Trump Media Announces Approximately $2.5 Billion Bitcoin Treasury Deal

SARASOTA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) ("Trump Media" or the "Company"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand …

Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

LEXINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient …

Stargaze Appoints Acclaimed Casting Directors Sharon Lieblein and Jamie Snow to Board of Directors

Stargaze Appoints Acclaimed Casting Directors Sharon Lieblein and Jamie Snow to Board of Directors

LOS ANGELES, May 27, 2025 (GLOBE NEWSWIRE) -- Stargaze Entertainment Group Inc. (“Stargaze” or the “Company”) (OTC PK: STGZ), a content creation and social platform designed to redefine talent discovery, has appointed acclaimed casting directors Sharon …

GCL Subsidiary’s Offer for Ban Leong Technologies Declared Unconditional in all Respects

GCL Subsidiary’s Offer for Ban Leong Technologies Declared Unconditional in all Respects

SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”) is a leading provider of games and entertainment and the indirect parent company of Epicsoft Asia Pte. Ltd. (the “Offeror”), the bidder seeking to …

Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation

Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation

NEEDHAM, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025

Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025

CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced an upcoming presentation at the …

CanadianSME Small Business Show 2025: Thriving in the Digital-First Economy

CanadianSME Small Business Show 2025: Thriving in the Digital-First Economy

MISSISSAUGA, Ontario, May 27, 2025 (GLOBE NEWSWIRE) -- The highly anticipated CanadianSME Small Business Show 2025 is set to return to the Metro Toronto Convention Centre – North Building, Level 100 on May 29, 2025, bringing together small business owners, …

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.

AUSTIN, Texas, May 27, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast …

New Study Reveals Agriculture as Largest, Most Resource-Intensive Industry on Earth

New Study Reveals Agriculture as Largest, Most Resource-Intensive Industry on Earth

BOSTON, May 27, 2025 (GLOBE NEWSWIRE) -- RA Capital Management’s Planetary Health Team and The Nature Conservancy have released a groundbreaking analysis that exposes agriculture as the most resource-intensive industry on Earth: it’s the leading …

Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies

Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies

CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced a strategic collaboration to …

Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Population Against Relevant, Immune-Evasive SARS-CoV-2…

Invivyd Announces Publication of Landmark CANOPY Phase 3 PEMGARDA® (pemivibart) Clinical Trial; Results Underscore Strong Efficacy of Monoclonal Antibodies in Preventing COVID-19 in a Modern U.S. Population Against Relevant, Immune-Evasive SARS-CoV-2…

CANOPY assessed pemivibart safety and tolerability, antiviral immunobridging, and exploratory efficacy against COVID-19, and is the only clinical trial of an authorized or approved COVID-19 monoclonal antibody or vaccine with placebo-controlled clinical …

Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

Tango Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference

BOSTON, May 27, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 46th Annual …

Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting

Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting

CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB) (Seres or the Company), a leading live biotherapeutics company, today announced the Company will be presenting new exploratory biomarker data from its SER-155 Phase …

EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration

EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration

– Over 400 patients enrolled and randomized over a seven-month period, driven by strong physician and patient interest – –  LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q …

Liberal strategist joins growing team at New West Public Affairs

Liberal strategist joins growing team at New West Public Affairs

OTTAWA, Ontario, May 27, 2025 (GLOBE NEWSWIRE) -- New West Public Affairs is pleased to announce that Jon Dugal has joined the firm as a Senior Consultant, Federal Affairs expanding the firm’s federal government relations capacity from its Ottawa office. …

Zhihu Inc. Reports Unaudited First Quarter 2025 Financial Results

Zhihu Inc. Reports Unaudited First Quarter 2025 Financial Results

BEIJING, China, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended March 31, 2025. First Quarter …

Zhihu Inc. Announces Change of Independent Director

Zhihu Inc. Announces Change of Independent Director

BEIJING, May 27, 2025 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced the appointment of Dr. Li-Lan Cheng as an independent director of the Company. Mr. Hanhui …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service